Skip to content

Effect of a Symptom Diary on Symptom Care and Symptom Burden in Patients Treated With Chemotherapy: a Before-and-after-study

Effect of the Implementation of a Symptom Diary on the Symptom Care Received and the Symptom Burden Experienced by Adult Cancer Patients Treated With Chemotherapy: A Before-and-after-study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02050490
Enrollment
236
Registered
2014-01-30
Start date
2014-01-31
Completion date
2016-12-31
Last updated
2023-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia, Etcetera, Nausea, Pain, Vomiting

Brief summary

This study investigates whether the implementation of a symptom diary for reporting and communicating chemotherapy-related symptoms improves symptom care and decreases symptom burden in adult patients treated with chemotherapy. The hypothesis is studied using a before-and-after design. First, symptom care and symptom burden will be observed in a sample of patients not being offered a symptom diary. Next, the symptom diary will be implemented at the participating hospital and symptom care and symptom burden will now be observed in a new sample of chemotherapy patients.

Interventions

None listed

Sponsors

Algemeen Ziekenhuis Maria Middelares
CollaboratorOTHER
Flemish League Against Cancer
CollaboratorOTHER
Onze Lieve Vrouw Hospital
CollaboratorOTHER
Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult (\>18) patients with (any type of) cancer treated with chemotherapy * Understanding Dutch * Being able to sign Informed consent

Exclusion criteria

* More than 3 lines of chemotherapy treatment in the past

Design outcomes

Primary

MeasureTime frameDescription
symptom distressT1 (cycle 1, day 1), T2 (cycle 2, day 1), T3 (cycle 3, day 1), T4 (cycle 5, day 1)for each of 9 symptoms: how distressing was the symptom perceived by the patient? (ordinal variable)

Secondary

MeasureTime frameDescription
symptom severityT1 (cycle 1, day 1), T2 (cycle 2, day 1), T3 (cycle 3, day 1), T4 (cycle 5, day 1)for each of 9 symptoms: how severe was the symptom? (ordinal variable)

Other

MeasureTime frameDescription
symptom careT1 (cycle 1, day 1), T2 (cycle 2, day 1), T3 (cycle 3, day 1)binary variable expressing whether the patient has received care (either medication or advice) to help with the symptom

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026